Loading...

MoonLake Immunotherapeutics Peer Comparison

Metric Value Ranking
Market Cap $2.8 Billion 4/13 CERE
$8.2B
NUVL
$5.8B
ACLX
$3.4B
MLTX
$2.8B
TVTX
$2.1B
ETNB
$1.6B
DAWN
$1.2B
CMPX
$516.0M
TERN
$368.6M
PLRX
$165.5M
VTYX
$114.6M
ABOS
$82.3M
AVTE
$70.7M
Gross Margin 0% 4/13 ACLX
100%
DAWN
92%
TVTX
80%
MLTX
0%
ETNB
0%
PLRX
0%
CERE
0%
AVTE
0%
CMPX
0%
TERN
0%
NUVL
0%
ABOS
0%
VTYX
0%
Profit Margin 0% 2/13 DAWN
100%
MLTX
0%
ETNB
0%
PLRX
0%
CERE
0%
AVTE
0%
CMPX
0%
TERN
0%
NUVL
0%
ABOS
0%
VTYX
0%
TVTX
-87%
ACLX
-99%
EBITDA margin -100% 3/13 DAWN
148%
TVTX
-87%
MLTX
-100%
ETNB
-100%
PLRX
-100%
CERE
-100%
AVTE
-100%
CMPX
-100%
TERN
-100%
NUVL
-100%
ABOS
-100%
VTYX
-100%
ACLX
-129%
Quarterly Revenue $0 4/13 TVTX
$62.9M
ACLX
$26.0M
DAWN
$20.1M
MLTX
$0
ETNB
$0
PLRX
$0
CERE
$0
AVTE
$0
CMPX
$0
TERN
$0
NUVL
$0
ABOS
$0
VTYX
$0
Quarterly Earnings -$35.9 Million 8/13 DAWN
$37.0M
CMPX
-$10.5M
AVTE
-$16.2M
TERN
-$21.9M
ACLX
-$25.9M
ABOS
-$29.8M
VTYX
-$35.2M
MLTX
-$35.9M
TVTX
-$54.8M
PLRX
-$57.8M
NUVL
-$84.3M
CERE
-$131.9M
ETNB
-$149.1M
Quarterly Free Cash Flow -$25.4 Million 8/13 ACLX
$28.4M
DAWN
-$5.0M
CMPX
-$11.1M
AVTE
-$16.0M
TERN
-$16.5M
TVTX
-$23.8M
ABOS
-$24.6M
MLTX
-$25.4M
PLRX
-$33.2M
VTYX
-$35.5M
NUVL
-$45.8M
CERE
-$119.9M
ETNB
-$145.4M
Trailing 4 Quarters Revenue $19,738 6/13 TVTX
$203.4M
ACLX
$155.8M
DAWN
$28.8M
PLRX
$4.8M
CMPX
$3.7M
MLTX
$19,738
ETNB
$0
CERE
$0
AVTE
$0
TERN
$0
NUVL
$0
ABOS
$0
VTYX
$0
Trailing 4 Quarters Earnings -$43.9 Billion 13/13 TVTX
$62.9M
ACLX
$26.0M
DAWN
$20.1M
MLTX
-$0
ETNB
-$0
PLRX
-$0
CERE
-$0
AVTE
-$0
CMPX
-$0
TERN
-$0
NUVL
-$0
ABOS
-$0
VTYX
-$0
Quarterly Earnings Growth -281% 12/13 DAWN
180%
VTYX
35%
ACLX
34%
TERN
26%
AVTE
17%
CMPX
-5%
CERE
-26%
PLRX
-39%
ABOS
-130%
TVTX
-136%
NUVL
-151%
MLTX
-281%
ETNB
-329%
Annual Earnings Growth -110161% 13/13 ACLX
63%
VTYX
51%
DAWN
50%
TERN
-6%
CMPX
-9%
AVTE
-10%
CERE
-20%
PLRX
-28%
ABOS
-71%
NUVL
-85%
ETNB
-93%
TVTX
-231%
MLTX
-110161%
Quarterly Revenue Growth 0% 3/13 ACLX
74%
TVTX
70%
MLTX
0%
ETNB
0%
PLRX
0%
CERE
0%
AVTE
0%
CMPX
0%
TERN
0%
NUVL
0%
DAWN
0%
ABOS
0%
VTYX
0%
Annual Revenue Growth 0% 3/13 PLRX
551%
ACLX
169%
MLTX
0%
ETNB
0%
CERE
0%
AVTE
0%
CMPX
0%
TERN
0%
NUVL
0%
DAWN
0%
ABOS
0%
VTYX
0%
TVTX
-6%
Cash On Hand $375.7 Million 2/13 DAWN
$422.8M
MLTX
$375.7M
NUVL
$369.2M
CERE
$320.4M
TERN
$270.1M
ACLX
$161.8M
ETNB
$91.4M
PLRX
$79.6M
VTYX
$61.8M
CMPX
$36.8M
TVTX
$36.4M
ABOS
$33.2M
AVTE
$31.1M
Short Term Debt $1.4 Million 4/13 TVTX
$73.9M
ACLX
$18.1M
CERE
$3.5M
MLTX
$1.4M
VTYX
$1.0M
ETNB
$743,000
CMPX
$557,000
AVTE
$459,000
PLRX
$322,000
TERN
$272,000
ABOS
$129,000
DAWN
$77,000
NUVL
-$0
Long Term Debt $1.9 Million 9/13 CERE
$364.8M
TVTX
$328.5M
PLRX
$59.9M
ACLX
$47.2M
ABOS
$29.9M
VTYX
$10.0M
CMPX
$6.3M
DAWN
$2.5M
MLTX
$1.9M
ETNB
$1.3M
TERN
$1.0M
AVTE
$81,000
NUVL
$0
PE -1.00 1/13 MLTX
-1.00
ETNB
-1.00
PLRX
-1.00
CERE
-1.00
AVTE
-1.00
CMPX
-1.00
TVTX
-1.00
TERN
-1.00
NUVL
-1.00
DAWN
-1.00
ABOS
-1.00
ACLX
-1.00
VTYX
-1.00
PS 141444.87 1/13 MLTX
141444.87
CMPX
139.67
DAWN
42.44
PLRX
34.20
ACLX
21.97
TVTX
10.16
ETNB
-1.00
CERE
-1.00
AVTE
-1.00
TERN
-1.00
NUVL
-1.00
ABOS
-1.00
VTYX
-1.00
PB 5.63 3/13 CERE
14.51
ACLX
7.09
MLTX
5.63
NUVL
5.15
ETNB
4.24
CMPX
3.73
DAWN
2.20
TERN
1.01
AVTE
0.88
PLRX
0.48
VTYX
0.41
ABOS
0.38
TVTX
0.00
PC 7.43 7/13 TVTX
56.77
CERE
25.56
ACLX
21.16
ETNB
17.55
NUVL
15.63
CMPX
14.02
MLTX
7.43
DAWN
2.89
ABOS
2.48
AVTE
2.27
PLRX
2.08
VTYX
1.85
TERN
1.36
Liabilities to Equity 0.05 11/13 CERE
1.00
ACLX
0.58
PLRX
0.29
ABOS
0.23
ETNB
0.21
AVTE
0.13
CMPX
0.08
DAWN
0.08
VTYX
0.08
NUVL
0.06
MLTX
0.05
TERN
0.04
TVTX
0.00
ROA -84.78 13/13 ACLX
-5%
DAWN
-15%
NUVL
-19%
TERN
-23%
ABOS
-31%
CMPX
-32%
VTYX
-35%
CERE
-41%
PLRX
-47%
ETNB
-63%
TVTX
-70%
AVTE
-93%
MLTX
-8478%
ROE -89.99 13/13 TVTX
1154%
ACLX
-8%
DAWN
-16%
NUVL
-20%
TERN
-24%
CMPX
-35%
ABOS
-38%
VTYX
-38%
PLRX
-61%
ETNB
-76%
CERE
-82%
AVTE
-105%
MLTX
-8999%
Current Ratio 22.82 2/13 TERN
27.48
MLTX
22.82
NUVL
17.55
CMPX
13.87
VTYX
13.49
DAWN
13.25
AVTE
8.69
ETNB
5.71
ABOS
5.36
PLRX
4.46
ACLX
2.71
CERE
2.00
TVTX
0.94
Quick Ratio 21.75 2/13 MLTX
-1.00
ETNB
-1.00
PLRX
-1.00
CERE
-1.00
AVTE
-1.00
CMPX
-1.00
TVTX
-1.00
TERN
-1.00
NUVL
-1.00
DAWN
-1.00
ABOS
-1.00
ACLX
-1.00
VTYX
-1.00
Long Term Debt to Equity 0.00 7/13 CERE}
0.65
PLRX}
0.17
ABOS}
0.14
ACLX}
0.10
CMPX}
0.05
VTYX}
0.04
MLTX}
0.00
ETNB}
0.00
AVTE}
0.00
TERN}
0.00
NUVL}
0.00
DAWN}
0.00
TVTX}
-10.79
Debt to Equity 0.01 7/13 CERE
0.65
PLRX
0.17
ABOS
0.14
ACLX
0.14
CMPX
0.05
VTYX
0.04
MLTX
0.01
ETNB
0.01
AVTE
0.01
TERN
0.00
NUVL
0.00
DAWN
0.00
TVTX
-13.21
Burn Rate 10.33 2/13 TERN
12.25
MLTX
10.33
ACLX
5.01
NUVL
4.38
CMPX
3.38
CERE
2.17
AVTE
1.90
VTYX
1.72
PLRX
1.32
ABOS
1.07
ETNB
0.61
TVTX
0.42
DAWN
-11.45
Cash to Cap 0.13 7/13 TERN
0.73
VTYX
0.54
PLRX
0.48
AVTE
0.44
ABOS
0.40
DAWN
0.35
MLTX
0.13
CMPX
0.07
ETNB
0.06
NUVL
0.06
ACLX
0.05
CERE
0.04
TVTX
0.02
CCR 0.71 8/13 CMPX
1.06
VTYX
1.01
AVTE
0.99
ETNB
0.98
CERE
0.91
ABOS
0.83
TERN
0.75
MLTX
0.71
PLRX
0.57
NUVL
0.54
TVTX
0.43
DAWN
-0.13
ACLX
-1.10
EV to EBITDA -67.17 12/13 DAWN}
27.10
ETNB}
-1.00
CERE}
-1.00
AVTE}
-1.00
TERN}
-1.00
NUVL}
-1.00
ABOS}
-1.00
VTYX}
-1.00
PLRX}
-2.36
CMPX}
-41.28
TVTX}
-44.44
MLTX}
-67.17
ACLX}
-98.99
EV to Revenue 122584.01 1/13 MLTX
122584.01
CMPX
131.57
PLRX
30.19
DAWN
27.86
ACLX
21.36
TVTX
11.96
ETNB
-1.00
CERE
-1.00
AVTE
-1.00
TERN
-1.00
NUVL
-1.00
ABOS
-1.00
VTYX
-1.00